Cryo-Save acquires the commercial activities of Salveo Biotechnology in Switzerland, Spain, Italy, Portugal and Ukraine. Frédéric Amar, Non-executive Director, now deeply involved in the company strategy

December 24, 2013 Group News
blood_new_salveo

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that it has signed an asset sale and purchase agreement to acquire all assets that are exclusively related to the distribution and commercial activities of the umbilical cord blood and umbilical cord tissue cryopreservation business of Salveo Biotechnology S.A., Switzerland and its subsidiaries, effective as of 1 January 2014.

read more

Child with cerebral palsy treated with umbilical cord blood derived autologous stem cells

December 12, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe announces that on December 10th 2013 a 4-year-old girl in Spain received an infusion of stem cells derived from her own umbilical cord blood for the treatment of her cerebral palsy. Cerebral palsy is one of the main areas of investigation of umbilical cord blood stem cell therapies.

read more

Cryo-Save Group N.V. – Q3 Trading Update

November 5, 2013 Group News
Tags
,

On track with implementation of “Fit for Future” turnaround plan

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces its trading update for the quarter ended 30 September 2013.

read more

In the year of the 25th anniversary of the first umbilical cord blood transplant Cryo-Save reaches 250,000 stored stem cell samples

October 7, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that it reached the major milestone of storing more than 250,000 stem cell samples since its foundation in 2000. At the same time, October 2013 marks the 25th anniversary of the first umbilical cord blood transplant performed by Dr. Eliane Gluckman in October 1988.

read more

Ms. Evi Mattil, CCO, will to take over the CEO functions ad interim

May 31, 2013 Group News
Tags
, ,

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that following on Mr. Arnoud van Tulder’s retirement as Chief Executive Officer, effective June 1, 2013, Ms. Evi Mattil, Chief Commercial Officer, will to take over with immediate effect and on an ad interim basis the functions of Arnoud van Tulder. The search and formal procedure for the nomination of a new CEO will be started immediately.

Cryo-Save strengthens management with chief commercial officer

February 1, 2013 Group News

Cryo-Save announced the appointment today of Ms. Evi Mattil as Chief Commercial Officer (CCO). She will be responsible for sales, marketing and communications worldwide. Ms. Mattil will be based at the company’s headquarter in Zurich. With more than 225,000 stem cell samples from umbilical cord blood and umbilical cord tissue, Cryo-Save is the largest family stem cell bank in Europe.

read more